Monoclonal antibodies reactive with the angiostatin receptor to replace angiostatin as an anti-tumor agent
Principal Investigator: Carol J. Wikstrand, PhD
Initiative: Unrestricted Grant
Institute: Duke University Medical Center
Location: Durham, NC